Global Dyslipidemia Market Analysis, 2020

By Type (Diagnosis & Monitoring Test, Drugs (Statin Drugs [High-intensity, Moderate-intensity, Low-intensity), Non-Statin Drugs, [Cholesterol Absorption Inhibitors, Bile Acid Sequesterants {Cholestyramine, Colesevelam, Cholybar, Colestipol}, Fibric Acid Derivatives, Niacins, PCSK9 inhibitors, Supplements of omega-3 fats])), By End-User (Clinics, Hospitals & Specialty Centers, Medical Laboratories, Others), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Spain, Italy, The Netherlands, Russia, China, Japan, South Korea, India, South East-Asia, Australia, UAE, Saudi Arabia, Egypt, Turkey, Nigeria, Israel, South Africa)

  • Healthcare
  • Jul 2020
  • 189
  • HC22028